Cita APA

Riddle, M. C., Aronson, R., Home, P., Marre, M., Niemoeller, E., Miossec, P., . . . Rosenstock, J. (2013). Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin: A 24-week, randomized, placebo-controlled comparison (GetGoal-L). American Diabetes Association.

Citación estilo Chicago

Riddle, Matthew C., Ronnie Aronson, Philip Home, Michel Marre, Elisabeth Niemoeller, Patrick Miossec, Lin Ping, Jenny Ye, y Julio Rosenstock. Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled By Established Basal Insulin: A 24-week, Randomized, Placebo-controlled Comparison (GetGoal-L). American Diabetes Association, 2013.

Cita MLA

Riddle, Matthew C., et al. Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled By Established Basal Insulin: A 24-week, Randomized, Placebo-controlled Comparison (GetGoal-L). American Diabetes Association, 2013.